{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:00:09Z","timestamp":1792292409111,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:00:00Z","timestamp":1606953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:00:00Z","timestamp":1606953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["1191006"],"award-info":[{"award-number":["1191006"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Obesity has been firmly established as a major risk factor for common disease states including hypertension, type 2 diabetes mellitus, and chronic kidney disease. Increased body mass index (BMI) contributes to the activation of both the systemic and intra-tubular renin angiotensin systems (RAS), which are in turn associated with increased blood pressure (BP) and kidney damage. In this cross-sectional study, 43 subjects of normal or increased body weight were examined in order to determine the correlation of BMI or body fat mass (BFM) with blood pressure, fasting blood glucose (FBG), and urinary kidney injury markers such as interleukin-18 (IL-18), connective tissue growth factor (CTGF), neutrophil gelatinase-associated lipocalin, and kidney injury molecule-1 (KIM-1). Our results showed that: (1) subjects with increased body weight showed significantly higher BP, BFM, total body water and metabolic age; (2) BMI was positively correlated to both systolic (R<jats:sup>2<\/jats:sup>\u2009=\u20090.1384, <jats:italic>P<\/jats:italic>\u2009=\u20090.01) and diastolic BP (R<jats:sup>2<\/jats:sup>\u2009=\u20090.2437, <jats:italic>P<\/jats:italic>\u2009=\u20090.0008); (3) BFM was positively correlated to DBP (R<jats:sup>2<\/jats:sup>\u2009=\u20090.1232, <jats:italic>P<\/jats:italic>\u2009=\u20090.02) and partially correlated to urine protein (R<jats:sup>2<\/jats:sup>\u2009=\u20090.047, <jats:italic>P<\/jats:italic>\u2009=\u20090.12) and FBG (R<jats:sup>2<\/jats:sup>\u2009=\u20090.07, <jats:italic>P<\/jats:italic>\u2009=\u20090.06); (4) overweight young adults had higher urinary mRNA levels of renin, angiotensinogen, IL-18 and CTGF. These suggest that BMI directly affects BP, kidney injury markers, and the activation of the intra-tubular RAS even in normotensive young adults. Given that BMI measurements and urine analyses are non-invasive, our findings may pave the way to developing a new and simple method of screening for the risk of chronic kidney disease in adults.<\/jats:p>","DOI":"10.1038\/s41598-020-78382-3","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T11:02:35Z","timestamp":1606993355000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Augmented transcripts of kidney injury markers and renin angiotensin system in urine samples of overweight young adults"],"prefix":"10.1038","volume":"10","author":[{"given":"Patricia","family":"Rivera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Rold\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Olave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"C\u00e1rdenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quynh My","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Modar","family":"Kassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis A.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,3]]},"reference":[{"key":"78382_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/sj.ijo.0802946","volume":"29","author":"AM Sharma","year":"2005","unstructured":"Sharma, A. M., Engeli, S. & Luft, F. The third international symposium on obesity and hypertension ISOH\u2019 03: \u201cgenetics and molecular mechanisms\u201d (October 23\u201325, 2003, Berlin Germany). Int. J. Obes. 29, 727\u2013734. https:\/\/doi.org\/10.1038\/sj.ijo.0802946 (2005).","journal-title":"Int. J. Obes."},{"key":"78382_CR2","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1001\/jama.2014.732","volume":"311","author":"CL Ogden","year":"2014","unstructured":"Ogden, C. L., Carroll, M. D., Kit, B. K. & Flegal, K. M. Prevalence of childhood and adult obesity in the United States, 2011\u20132012. JAMA 311, 806\u2013814. https:\/\/doi.org\/10.1001\/jama.2014.732 (2014).","journal-title":"JAMA"},{"key":"78382_CR3","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1161\/CIRCULATIONAHA.117.029617","volume":"137","author":"IJ Neeland","year":"2018","unstructured":"Neeland, I. J., Poirier, P. & Despres, J. P. Cardiovascular and metabolic heterogeneity of obesity: clinical challenges and implications for management. Circulation 137, 1391\u20131406. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.029617 (2018).","journal-title":"Circulation"},{"key":"78382_CR4","doi-asserted-by":"publisher","first-page":"F316","DOI":"10.1152\/ajprenal.00162.2018","volume":"316","author":"KC McPherson","year":"2019","unstructured":"McPherson, K. C. et al. Impact of obesity as an independent risk factor for the development of renal injury: implications from rat models of obesity. Am. J. Physiol. Renal Physiol. 316, F316\u2013F327. https:\/\/doi.org\/10.1152\/ajprenal.00162.2018 (2019).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"78382_CR5","first-page":"28","volume":"170","author":"C Maric","year":"2011","unstructured":"Maric, C. & Hall, J. E. Obesity, metabolic syndrome and diabetic nephropathy. Diabetes Kidney 170, 28\u201335 (2011).","journal-title":"Diabetes Kidney"},{"key":"78382_CR6","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","volume":"116","author":"JE Hall","year":"2015","unstructured":"Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z. & Hall, M. E. Obesity-induced hypertension interaction of neurohumoral and renal mechanisms. Circ. Res. 116, 991\u20131006. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.305697 (2015).","journal-title":"Circ. Res."},{"key":"78382_CR7","doi-asserted-by":"publisher","first-page":"R943","DOI":"10.1152\/ajpregu.00265.2004","volume":"287","author":"CM Boustany","year":"2004","unstructured":"Boustany, C. M. et al. Activation of the systemic and adipose renin\u2013angiotensin system in rats with diet-induced obesity and hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287, R943\u2013R949. https:\/\/doi.org\/10.1152\/ajpregu.00265.2004 (2004).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"78382_CR8","unstructured":"Fountain, J. H. & Lappin, S. L. in StatPearls (2018)."},{"key":"78382_CR9","doi-asserted-by":"publisher","first-page":"S114","DOI":"10.1177\/14703203010020012001","volume":"2","author":"AM Sharma","year":"2001","unstructured":"Sharma, A. M. & Engeli, S. The renin\u2013angiotensin system in obesity hypertension. J. Renin Angiotensin Aldosterone Syst. JRAAS 2, S114\u2013S119. https:\/\/doi.org\/10.1177\/14703203010020012001 (2001).","journal-title":"J. Renin Angiotensin Aldosterone Syst. JRAAS"},{"key":"78382_CR10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s11906-012-0245-z","volume":"14","author":"T Thethi","year":"2012","unstructured":"Thethi, T., Kamiyama, M. & Kobori, H. The link between the renin\u2013angiotensin\u2013aldosterone system and renal injury in obesity and the metabolic syndrome. Curr. Hypertens Rep. 14, 160\u2013169. https:\/\/doi.org\/10.1007\/s11906-012-0245-z (2012).","journal-title":"Curr. Hypertens Rep."},{"key":"78382_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd6020014","author":"A Nehme","year":"2019","unstructured":"Nehme, A., Zouein, F. A., Zayeri, Z. D. & Zibara, K. An update on the tissue renin angiotensin system and its role in physiology and pathology. J. Cardiovasc. Dev. Dis. https:\/\/doi.org\/10.3390\/jcdd6020014 (2019).","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"78382_CR12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1124\/pr.59.3.3","volume":"59","author":"H Kobori","year":"2007","unstructured":"Kobori, H., Nangaku, M., Navar, L. G. & Nishiyama, A. The intrarenal renin\u2013angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol. Rev. 59, 251\u2013287. https:\/\/doi.org\/10.1124\/pr.59.3.3 (2007).","journal-title":"Pharmacol. Rev."},{"key":"78382_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000060154","volume":"135","author":"LG Navar","year":"2001","unstructured":"Navar, L. G. & Nishiyama, A. Intrarenal formation of angiotensin II. Contrib. Nephrol. 135, 1\u201315 (2001).","journal-title":"Contrib. Nephrol."},{"key":"78382_CR14","doi-asserted-by":"publisher","first-page":"F632","DOI":"10.1152\/ajprenal.00462.2004","volume":"289","author":"MC Prieto-Carrasquero","year":"2005","unstructured":"Prieto-Carrasquero, M. C. et al. AT(1) receptor- mediated enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. Am. J. Physiol. Renal 289, F632\u2013F637. https:\/\/doi.org\/10.1152\/ajprenal.00462.2004 (2005).","journal-title":"Am. J. Physiol. Renal"},{"key":"78382_CR15","doi-asserted-by":"publisher","first-page":"F405","DOI":"10.1152\/ajprenal.1997.272.3.F405","volume":"272","author":"DE Casarini","year":"1997","unstructured":"Casarini, D. E. et al. Angiotensin I-converting enzyme activity in tubular fluid along the rat nephron. Am. J. Physiol. Renal 272, F405\u2013F409 (1997).","journal-title":"Am. J. Physiol. Renal"},{"key":"78382_CR16","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1681\/ASN.V123431","volume":"12","author":"H Kobori","year":"2001","unstructured":"Kobori, H., Harrison-Bernard, L. M. & Navar, L. G. Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension. J. Am. Soc. Nephrol. 12, 431\u2013439 (2001).","journal-title":"J. Am. Soc. Nephrol."},{"key":"78382_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1161\/01.HYP.0000135678.20725.54","volume":"44","author":"MC Prieto-Carrasquero","year":"2004","unstructured":"Prieto-Carrasquero, M. C. et al. Enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. Hypertension 44, 223\u2013229. https:\/\/doi.org\/10.1161\/01.HYP.0000135678.20725.54 (2004).","journal-title":"Hypertension"},{"key":"78382_CR18","doi-asserted-by":"publisher","first-page":"F632","DOI":"10.1152\/ajprenal.00462.2004","volume":"289","author":"MC Prieto-Carrasquero","year":"2005","unstructured":"Prieto-Carrasquero, M. C. et al. AT1 receptor-mediated enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. Am. J. Physiol. Renal Physiol. 289, F632-637. https:\/\/doi.org\/10.1152\/ajprenal.00462.2004 (2005).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"78382_CR19","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1161\/HYPERTENSIONAHA.108.110916","volume":"51","author":"MC Prieto-Carrasquero","year":"2008","unstructured":"Prieto-Carrasquero, M. C. et al. Collecting duct renin is upregulated in both kidneys of 2-kidney, 1-clip goldblatt hypertensive rats. Hypertension 51, 1590\u20131596 (2008).","journal-title":"Hypertension"},{"key":"78382_CR20","doi-asserted-by":"publisher","first-page":"F1067","DOI":"10.1152\/ajprenal.90596.2008","volume":"296","author":"WJ Shao","year":"2009","unstructured":"Shao, W. J., Seth, D. M. & Navar, L. G. Augmentation of endogenous intrarenal angiotensin II levels in Val(5)-ANG II-infused rats. Am. J. Physiol. Renal 296, F1067\u2013F1071. https:\/\/doi.org\/10.1152\/ajprenal.90596.2008 (2009).","journal-title":"Am. J. Physiol. Renal"},{"key":"78382_CR21","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0950-351X(89)80009-6","volume":"3","author":"KD Mitchell","year":"1989","unstructured":"Mitchell, K. D. & Navar, L. G. The renin\u2013angiotensin\u2013aldosterone system in volume control. Baillieres Clin. Endocrinol. Metab. 3, 393\u2013430 (1989).","journal-title":"Baillieres Clin. Endocrinol. Metab."},{"key":"78382_CR22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s11906-003-0070-5","volume":"5","author":"LG Navar","year":"2003","unstructured":"Navar, L. G., Kobori, H. & Prieto-Carrasquero, M. Intrarenal angiotensin II and hypertension. Curr. Hypertens Rep. 5, 135\u2013143 (2003).","journal-title":"Curr. Hypertens Rep."},{"key":"78382_CR23","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.coph.2011.01.009","volume":"11","author":"LG Navar","year":"2011","unstructured":"Navar, L. G., Prieto, M. C., Satou, R. & Kobori, H. Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension. Curr. Opin. Pharmacol. 11, 180\u2013186. https:\/\/doi.org\/10.1016\/j.coph.2011.01.009 (2011).","journal-title":"Curr. Opin. Pharmacol."},{"key":"78382_CR24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/kisup.2013.67","volume":"3","author":"LG Navar","year":"2013","unstructured":"Navar, L. G. Translational studies on augmentation of intratubular renin\u2013angiotensin system in hypertension. Kidney Int. Suppl. 3, 321\u2013325. https:\/\/doi.org\/10.1038\/kisup.2013.67 (2013).","journal-title":"Kidney Int. Suppl."},{"key":"78382_CR25","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1161\/Hypertensionaha.108.123802","volume":"53","author":"H Kobori","year":"2009","unstructured":"Kobori, H. et al. Urinary angiotensinogen as a novel biomarker of the intrarenal renin\u2013angiotensin system status in hypertensive patients. Hypertension 53, 344-U407. https:\/\/doi.org\/10.1161\/Hypertensionaha.108.123802 (2009).","journal-title":"Hypertension"},{"key":"78382_CR26","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1097\/HJH.0b013e3283392673","volume":"28","author":"H Kobori","year":"2010","unstructured":"Kobori, H., Urushihara, M., Xu, J. H., Berenson, G. S. & Navar, L. G. Urinary angiotensinogen is correlated with blood pressure in men (Bogalusa Heart Study). J. Hypertens 28, 1422\u20131428. https:\/\/doi.org\/10.1097\/HJH.0b013e3283392673 (2010).","journal-title":"J. Hypertens"},{"key":"78382_CR27","doi-asserted-by":"publisher","first-page":"e14242","DOI":"10.14814\/phy2.14242","volume":"7","author":"S Ba Aqeel","year":"2019","unstructured":"Ba Aqeel, S. et al. Urinary angiotensinogen antedates the development of stage 3 CKD in patients with type 1 diabetes mellitus. Physiol. Rep. 7, e14242. https:\/\/doi.org\/10.14814\/phy2.14242 (2019).","journal-title":"Physiol. Rep."},{"key":"78382_CR28","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.kint.2017.11.024","volume":"93","author":"N Nowak","year":"2018","unstructured":"Nowak, N. et al. Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development. Kidney Int. 93, 1198\u20131206. https:\/\/doi.org\/10.1016\/j.kint.2017.11.024 (2018).","journal-title":"Kidney Int."},{"key":"78382_CR29","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2215\/CJN.03520807","volume":"3","author":"SG Coca","year":"2008","unstructured":"Coca, S. G. & Parikh, C. R. Urinary biomarkers for acute kidney injury: perspectives on translation. Clin. J. Am. Soc. Nephrol. CJASN 3, 481\u2013490. https:\/\/doi.org\/10.2215\/CJN.03520807 (2008).","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN"},{"key":"78382_CR30","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1681\/ASN.2009030264","volume":"21","author":"IE Hall","year":"2010","unstructured":"Hall, I. E. et al. IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. J. Am. Soc. Nephrol. 21, 189\u2013197. https:\/\/doi.org\/10.1681\/ASN.2009030264 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"78382_CR31","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2337\/dc10-1545","volume":"34","author":"FL Nauta","year":"2011","unstructured":"Nauta, F. L. et al. Glomerular and tubular damage markers are elevated in patients with diabetes. Diabetes Care 34, 975\u2013981. https:\/\/doi.org\/10.2337\/dc10-1545 (2011).","journal-title":"Diabetes Care"},{"key":"78382_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00467-014-2976-3","volume":"30","author":"W Ding","year":"2015","unstructured":"Ding, W. & Mak, R. H. Early markers of obesity-related renal injury in childhood. Pediatr. Nephrol. 30, 1\u20134. https:\/\/doi.org\/10.1007\/s00467-014-2976-3 (2015).","journal-title":"Pediatr. Nephrol."},{"key":"78382_CR33","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.2337\/Diacare.26.9.2632","volume":"26","author":"RE Gilbert","year":"2003","unstructured":"Gilbert, R. E. et al. Urinary connective tissue growth factor excretion in patients with type 1 diabetes and nephropathy. Diabetes Care 26, 2632\u20132636. https:\/\/doi.org\/10.2337\/Diacare.26.9.2632 (2003).","journal-title":"Diabetes Care"},{"key":"78382_CR34","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/00126097-200306000-00002","volume":"8","author":"S Fonseca-Reyes","year":"2003","unstructured":"Fonseca-Reyes, S., de Alba-Garcia, J. G., Parra-Carrillo, J. Z. & Paczka-Zapata, J. A. Effect of standard cuff on blood pressure readings in patients with obese arms. How frequent are arms of a \u201clarge circumference\u201d?. Blood Press. Monit. 8, 101\u2013106. https:\/\/doi.org\/10.1097\/00126097-200306000-00002 (2003).","journal-title":"Blood Press. Monit."},{"key":"78382_CR35","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.1210\/jcem.86.9.7760","volume":"86","author":"RS Lindsay","year":"2001","unstructured":"Lindsay, R. S. et al. Body mass index as a measure of adiposity in children and adolescents: relationship to adiposity by dual energy x-ray absorptiometry and to cardiovascular risk factors. J. Clin. Endocrinol. Metab. 86, 4061\u20134067. https:\/\/doi.org\/10.1210\/jcem.86.9.7760 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"78382_CR36","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.2337\/dc09-1766","volume":"33","author":"RS Lindsay","year":"2010","unstructured":"Lindsay, R. S. et al. Programming of adiposity in offspring of mothers with type 1 diabetes at age 7 years. Diabetes Care 33, 1080\u20131085. https:\/\/doi.org\/10.2337\/dc09-1766 (2010).","journal-title":"Diabetes Care"},{"key":"78382_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1053\/j.arrt.2003.10.007","volume":"11","author":"JE Hall","year":"2004","unstructured":"Hall, J. E. et al. Is obesity a major cause of chronic kidney disease?. Adv. Renal Replace. Ther. 11, 41\u201354. https:\/\/doi.org\/10.1053\/j.arrt.2003.10.007 (2004).","journal-title":"Adv. Renal Replace. Ther."},{"key":"78382_CR38","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11906-008-0019-9","volume":"10","author":"LA Cassis","year":"2008","unstructured":"Cassis, L. A., Police, S. B., Yiannikouris, F. & Thatcher, S. E. Local adipose tissue renin\u2013angiotensin system. Curr. Hypertens Rep. 10, 93\u201398 (2008).","journal-title":"Curr. Hypertens Rep."},{"key":"78382_CR39","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1046\/J.1523-1755.2001.00776.X","volume":"60","author":"SN Wang","year":"2001","unstructured":"Wang, S. N., DeNichilo, M., Brubaker, C. & Hirschberg, R. Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy. Kidney Int. 60, 96\u2013105. https:\/\/doi.org\/10.1046\/J.1523-1755.2001.00776.X (2001).","journal-title":"Kidney Int."},{"key":"78382_CR40","doi-asserted-by":"publisher","first-page":"6630","DOI":"10.1038\/s41598-018-24340-z","volume":"8","author":"S Kilari","year":"2018","unstructured":"Kilari, S., Yang, B., Sharma, A., McCall, D. L. & Misra, S. Increased transforming growth factor beta (TGF-beta) and pSMAD3 signaling in a murine model for contrast induced kidney injury. Sci. Rep. 8, 6630. https:\/\/doi.org\/10.1038\/s41598-018-24340-z (2018).","journal-title":"Sci. Rep."},{"key":"78382_CR41","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/539787","author":"KGF Gerritsen","year":"2015","unstructured":"Gerritsen, K. G. F. et al. Elevated urinary connective tissue growth factor in diabetic nephropathy is caused by local production and tubular dysfunction. J. Diabetes Res. https:\/\/doi.org\/10.1155\/2015\/539787 (2015).","journal-title":"J. Diabetes Res."},{"key":"78382_CR42","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2337\/diacare.29.1.83","volume":"29","author":"TQ Nguyen","year":"2006","unstructured":"Nguyen, T. Q. et al. Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy. Diabetes Care 29, 83\u201388. https:\/\/doi.org\/10.2337\/diacare.29.1.83 (2006).","journal-title":"Diabetes Care"},{"key":"78382_CR43","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1046\/j.1523-1755.2002.00433.x","volume":"62","author":"WK Han","year":"2002","unstructured":"Han, W. K., Bailly, V., Abichandani, R., Thadhani, R. & Bonventre, J. V. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 62, 237\u2013244. https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00433.x (2002).","journal-title":"Kidney Int."},{"key":"78382_CR44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000209379","volume":"32","author":"D Bolignano","year":"2009","unstructured":"Bolignano, D. et al. Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. Kidney Blood Press. Res. 32, 91\u201398. https:\/\/doi.org\/10.1159\/000209379 (2009).","journal-title":"Kidney Blood Press. Res."},{"key":"78382_CR45","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1097\/01.asn.0000088027.54400.c6","volume":"14","author":"J Mishra","year":"2003","unstructured":"Mishra, J. et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J. Am. Soc. Nephrol. 14, 2534\u20132543. https:\/\/doi.org\/10.1097\/01.asn.0000088027.54400.c6 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"78382_CR46","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1111\/ajt.13891","volume":"16","author":"P Galichon","year":"2016","unstructured":"Galichon, P. et al. Urinary mRNA for the diagnosis of renal allograft rejection: the issue of normalization. Am. J. Transplant. 16, 3033\u20133040. https:\/\/doi.org\/10.1111\/ajt.13891 (2016).","journal-title":"Am. J. Transplant."},{"key":"78382_CR47","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/imr.12159","volume":"258","author":"JR Lee","year":"2014","unstructured":"Lee, J. R. et al. Urinary cell mRNA profiles predictive of human kidney allograft status. Immunol. Rev. 258, 218\u2013240. https:\/\/doi.org\/10.1111\/imr.12159 (2014).","journal-title":"Immunol. Rev."},{"key":"78382_CR48","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/j.0300-9475.2004.01440.x","volume":"59","author":"A Bas","year":"2004","unstructured":"Bas, A., Forsberg, G., Hammarstrom, S. & Hammarstrom, M. L. Utility of the housekeeping genes 18S rRNA, beta-actin and glyceraldehyde-3-phosphate-dehydrogenase for normalization in real-time quantitative reverse transcriptase-polymerase chain reaction analysis of gene expression in human T lymphocytes. Scand. J. Immunol. 59, 566\u2013573. https:\/\/doi.org\/10.1111\/j.0300-9475.2004.01440.x (2004).","journal-title":"Scand. J. Immunol."},{"key":"78382_CR49","doi-asserted-by":"publisher","first-page":"9604740","DOI":"10.1155\/2019\/9604740","volume":"2019","author":"V Selvaraju","year":"2019","unstructured":"Selvaraju, V. et al. Urinary biomarkers of inflammation and oxidative stress are elevated in obese children and correlate with a marker of endothelial dysfunction. Oxid. Med. Cell. Longev. 2019, 9604740. https:\/\/doi.org\/10.1155\/2019\/9604740 (2019).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"78382_CR50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40608-017-0148-2","volume":"4","author":"R Singh","year":"2017","unstructured":"Singh, R., Verma, A., Aljabari, S. & Vasylyeva, T. L. Urinary biomarkers as indicator of chronic inflammation and endothelial dysfunction in obese adolescents. BMC Obes. 4, 11. https:\/\/doi.org\/10.1186\/s40608-017-0148-2 (2017).","journal-title":"BMC Obes."},{"key":"78382_CR51","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1097\/HJH.0b013e32834bbcbf","volume":"29","author":"M van den Heuvel","year":"2011","unstructured":"van den Heuvel, M. et al. Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin\u2013angiotensin\u2013aldosterone system activity and the efficacy of renin\u2013angiotensin\u2013aldosterone system blockade in the kidney. J. Hypertens 29, 2147\u20132155. https:\/\/doi.org\/10.1097\/HJH.0b013e32834bbcbf (2011).","journal-title":"J. Hypertens"},{"key":"78382_CR52","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1161\/HYPERTENSIONAHA.119.12873","volume":"74","author":"J Tang","year":"2019","unstructured":"Tang, J. et al. Urinary renin in patients and mice with diabetic kidney disease. Hypertension 74, 83\u201394. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.119.12873 (2019).","journal-title":"Hypertension"},{"key":"78382_CR53","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1161\/Hypertensionaha.107.107268","volume":"51","author":"JJ Kang","year":"2008","unstructured":"Kang, J. J. et al. The collecting duct is the major source of prorenin in diabetes. Hypertension 51, 1597\u20131604. https:\/\/doi.org\/10.1161\/Hypertensionaha.107.107268 (2008).","journal-title":"Hypertension"},{"key":"78382_CR54","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/ki.2010.333","volume":"78","author":"J Peti-Peterdi","year":"2010","unstructured":"Peti-Peterdi, J. High glucose and renin release: the role of succinate and GPR91. Kidney Int. 78, 1214\u20131217. https:\/\/doi.org\/10.1038\/ki.2010.333 (2010).","journal-title":"Kidney Int."},{"key":"78382_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/nu10121976","author":"F Landi","year":"2018","unstructured":"Landi, F. et al. Body mass index is strongly associated with hypertension: results from the longevity check-up 7+ study. Nutrients https:\/\/doi.org\/10.3390\/nu10121976 (2018).","journal-title":"Nutrients"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78382-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78382-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78382-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:01:28Z","timestamp":1670371288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78382-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,3]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["78382"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-78382-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,3]]},"assertion":[{"value":"2 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21154"}}